Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Jefferies Financial Group
JEF
$13.7B
| $573K | ﹤0.01% |
+17,289
| New | +$573K |
|
2802
WisdomTree US LargeCap Dividend Fund
DLN
$5.31B
| $572K | ﹤0.01% |
+9,000
| New | +$572K |
|
2803
scPharmaceuticals
SCPH
$302M
| $569K | ﹤0.01% |
55,886
-125,100
| -69% | -$1.27M |
|
2804
Ormat Technologies
ORA
$5.53B
| $568K | ﹤0.01% |
+7,056
| New | +$568K |
|
2805
Schwab US REIT ETF
SCHH
$8.43B
| $568K | ﹤0.01% |
+29,100
| New | +$568K |
|
2806
Veeco
VECO
$1.52B
| $568K | ﹤0.01% |
+22,110
| New | +$568K |
|
2807
Eltek
ELTK
$68.1M
| $567K | ﹤0.01% |
60,623
-1,831
| -3% | -$17.1K |
|
2808
Cue Biopharma
CUE
$57M
| $566K | ﹤0.01% |
155,000
+103,900
| +203% | +$379K |
|
2809
Biglari Holdings Class B
BH
$943M
| $563K | ﹤0.01% |
2,856
-63
| -2% | -$12.4K |
|
2810
Babcock & Wilcox
BW
$281M
| $562K | ﹤0.01% |
+95,308
| New | +$562K |
|
2811
SCYNEXIS
SCYX
$47M
| $562K | ﹤0.01% |
190,580
+173,480
| +1,015% | +$512K |
|
2812
Nuvation Bio
NUVB
$1.07B
| $561K | ﹤0.01% |
311,900
+38,800
| +14% | +$69.8K |
|
2813
Monte Rosa Therapeutics
GLUE
$297M
| $560K | ﹤0.01% |
81,800
+53,900
| +193% | +$369K |
|
2814
Pearson
PSO
$9.15B
| $560K | ﹤0.01% |
+53,400
| New | +$560K |
|
2815
Betterware México
BWMX
$500M
| $559K | ﹤0.01% |
43,200
-400
| -0.9% | -$5.18K |
|
2816
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$4.28B
| $558K | ﹤0.01% |
17,800
-3,100
| -15% | -$97.2K |
|
2817
iShares Core S&P US Growth ETF
IUSG
$25.3B
| $557K | ﹤0.01% |
5,700
+3,300
| +138% | +$322K |
|
2818
Custom Truck One Source
CTOS
$1.29B
| $556K | ﹤0.01% |
82,500
+43,229
| +110% | +$291K |
|
|
SELF
2819
Global Self Storage
SELF
$58.4M
| $556K | ﹤0.01% |
110,056
-16,334
| -13% | -$82.5K |
|
2820
Xtant Medical Holdings
XTNT
$82.2M
| $555K | ﹤0.01% |
597,010
-5,800
| -1% | -$5.39K |
|
|
AINC
2821
DELISTED
Ashford Inc.
AINC
| $555K | ﹤0.01% |
57,053
-2,600
| -4% | -$25.3K |
|
2822
Affinity Bancshares
AFBI
$123M
| $554K | ﹤0.01% |
47,400
-3,804
| -7% | -$44.5K |
|
2823
Regenxbio
RGNX
$465M
| $554K | ﹤0.01% |
+27,700
| New | +$554K |
|
2824
Vanguard Mid-Cap Value ETF
VOE
$18.9B
| $554K | ﹤0.01% |
+4,000
| New | +$554K |
|
2825
Dimensional International Core Equity 2 ETF
DFIC
$10.4B
| $551K | ﹤0.01% |
22,700
+3,200
| +16% | +$77.7K |
|